ArticleBiology of reproduction2026
Interleukin-6 and leukemia inhibitory factor differentially modify embryonic disk composition in post hatching bovine embryos†.
Article in Biology of reproduction, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Molecular Regulation of Post-Hatching Embryo Development: Implications for Early Pregnancy Losses in Livestock Species.Reproduction in domestic animals = Zuchthygiene · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Proper formation of the embryonic disk is essential for pregnancy survival. This study examined whether supplementing interleukin-6 (IL6) or leukemia inhibitory factor (LIF) influence epiblast (EPI) and hypoblast (HYPO) development as well as other facets of post-hatching bovine embryo development in an extended culture system. A series of three studies were completed where in vitro-produced (IVP) embryos were treated with IL6 or LIF from days 5-12, 5-7, or 7-12 post-fertilization. Survival and hatching were monitored from days 7-12, then embryos were fixed for immunofluorescent assessments. Non-treated IVP embryos were transferred at day 7 and collected on day 12 post-estrus (IVP-ET) for use an in-utero reference for the days 7-12 culture group. Neither IL6 nor LIF affected survival or hatching. Supplementing IL6 from days 5-12 increased EPI cell number and reduced HYPO formation, whereas LIF had no effect. Supplementing IL6 from days 7-12 produced similar responses, and EPI cell numbers matched those of the IVP-ET day 12 embryos. By contrast, supplementing IL6 from days 5-7 had no effects, indicating that IL6 exposure is unnecessary before blastocyst formation but required afterward to elicit these outcomes. In conclusion, IL6 supplementation after blastocyst formation enhances EPI development to levels comparable to in utero embryos, although this may occur at the expense of HYPO formation. It was equally intriguing that LIF did not mimic the effects of IL6 but rather failed to exhibit any noteworthy effects on the EPI and HYPO lineages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.